GlassScriptPhysician profile
Dominick Giuffrida
NPI 1063480135
$6,798.27
in general payments reported to CMS, 2019-2025
40 companies · $1,462 in 2025
The $1,462 reported for 2025 was more than what 93% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,006 · 2020: $188 · 2021: $525 · 2022: $1,383 · 2023: $1,266 · 2024: $968 · 2025: $1,462.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,656 · Education: $40.05.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,656.39 |
| Education | $40.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,192.90 | 2019-2025 | |
| Mayne Pharma Commercial LLC | $544.35 | 2022-2025 | |
| Amgen INC. | $504.15 | 2019-2023 | Prolia, Evenity |
| Daiichi Sankyo INC. | $493.57 | 2019-2025 | Injectafer |
| Shield Therapeutics INC | $385.39 | 2023-2025 | Accrufer |
| Astellas Pharma US INC | $374.91 | 2023-2025 | Veozah |
| Myriad Women'S Health, INC. | $365.21 | 2023 | Myrisk |
| Sage Therapeutics, LLC | $250.70 | 2025 | Zurzuvae |
| Myovant Sciences INC. | $249.87 | 2021-2022 | |
| Exeltis, USA INC. | $235.74 | 2020-2025 | Slynd |
| Novo Nordisk INC | $217.31 | 2021-2022 | |
| Mylan Pharmaceuticals INC. | $207.52 | 2019-2022 | |
| Therapeuticsmd, INC. | $191.10 | 2020-2022 | |
| Coopersurgical, INC. | $169.49 | 2019-2024 | Paragard T 380a, Paragard T 380a |
| Sumitomo Pharma America, INC. | $151.56 | 2023-2025 | Myfembree |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Millicent US INC | $115.20 | 2019-2025 | Intrarosa, Femlyv, Femring |
| Allergan, INC. | $105.00 | 2019-2020 | |
| Pfizer INC. | $90.38 | 2021-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $86.56 | 2024-2025 | Xifaxan |
| Aspira Women'S Health INC | $77.62 | 2024 | Ova1 |
| Avion Pharmaceuticals | $71.51 | 2021-2023 | Balcoltra |
| Baxter Healthcare | $69.37 | 2024-2025 | Perclot |
| Organon LLC | $57.24 | 2022-2023 | Nexplanon |
| Evofem Biosciences, INC. | $57.19 | 2023-2025 | Phexxi, Solosec, Phexx |
| Mimedx Group, INC. | $55.49 | 2024-2025 | |
| Hologic Sales and Service, LLC | $50.96 | 2024-2025 | Aptima, Thinprep 2000 Processor |
| Supernus Pharmaceuticals, INC. | $48.34 | 2025 | Qelbree |
| Alexion Pharmaceuticals, INC. | $47.89 | 2019 | |
| Amag Pharmaceuticals, INC. | $41.22 | 2019 | |
| Duchesnay USA Incorporated | $41.13 | 2019 | |
| Urovant Sciences INC | $41.10 | 2022 | |
| Exact Sciences Corporation | $39.12 | 2025 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $30.58 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $26.50 | 2019 | |
| Avanos Medical | $23.56 | 2019 | |
| Meditrina | $20.30 | 2023 | |
| Caldera Medical, INC | $19.43 | 2023 | Desara |
| Lilly USA, LLC | $19.11 | 2024 | Mounjaro |
| Ethicon US, LLC | $17.53 | 2024 | Stratafix, Surgicel Nu-Knit |
| Agile Therapeutics, INC. | $12.17 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dominick Giuffrida listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.